Three insights:
1. The company aims to use the net proceeds for working capital and other corporate purposes.
2. All shares in the offering are to be sold by SeaSpine.
3. SeaSpine plans to give the underwriters a 30-day option to buy up to an additional 15 percent of the shares of common stock offered in the public offering.
More articles on devices:
Orthopedic clinic faces renewed lawsuit over 2016 cyberattack
Orthopedics unit restructures workforce to boost efficiency — 5 details
Optim Orthopedics performs four free joint replacements
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.